华人健康
(301408)
| 流通市值：32.01亿 | | | 总市值：55.92亿 |
| 流通股本：2.29亿 | | | 总股本：4.00亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 4,314,724,831.34 | 2,824,690,091.29 | 1,420,983,890.57 | 5,486,683,545.91 |
| 营业总成本 | 4,005,418,466 | 2,625,439,993.61 | 1,306,494,171.94 | 5,115,071,415.63 |
| 其他经营收益 | | | | |
| 营业利润 | 313,310,159.17 | 201,966,310.38 | 111,772,319.62 | 300,182,917.69 |
| 利润总额 | 310,757,177.61 | 200,300,688.39 | 110,790,242.3 | 294,390,720.4 |
| 净利润 | 232,623,094.2 | 148,404,786.67 | 86,083,860.45 | 213,866,632.27 |
| 每股收益 | | | | |
| 其他综合收益 | 0 | - | - | 1,400,217.49 |
| 综合收益总额 | 232,623,094.2 | 148,404,786.67 | 86,083,860.45 | 215,266,849.76 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 3,493,755,810.63 | 2,883,609,566.26 | 2,982,310,973.37 | 2,912,921,351.49 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,657,976,158.48 | 2,584,651,343.07 | 2,568,781,092.73 | 2,575,411,789.98 |
| 资产总计 | 6,151,731,969.11 | 5,468,260,909.33 | 5,551,092,066.1 | 5,488,333,141.47 |
| 流动负债: | | | | |
| 流动负债合计 | 3,276,963,514.35 | 2,669,267,621.07 | 2,648,791,813.92 | 2,685,555,698.23 |
| 非流动负债: | | | | |
| 非流动负债合计 | 614,790,719.11 | 625,193,860.14 | 658,552,578.94 | 639,673,630.45 |
| 负债合计 | 3,891,754,233.46 | 3,294,461,481.21 | 3,307,344,392.86 | 3,325,229,328.68 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,198,524,924.14 | 2,118,892,308.38 | 2,176,321,049.16 | 2,096,977,526.88 |
| 股东权益合计 | 2,259,977,735.65 | 2,173,799,428.12 | 2,243,747,673.24 | 2,163,103,812.79 |
| 负债和股东权益合计 | 6,151,731,969.11 | 5,468,260,909.33 | 5,551,092,066.1 | 5,488,333,141.47 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 4,457,220,523.14 | 3,073,766,239.18 | 1,479,584,025.26 | 5,407,080,653.17 |
| 经营活动现金流出小计 | 3,815,538,113.94 | 2,664,123,623.01 | 1,175,035,905.76 | 4,569,899,484.68 |
| 经营活动产生的现金流量净额 | 641,682,409.2 | 409,642,616.17 | 304,548,119.5 | 837,181,168.49 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,449,875,654.63 | 844,556,694.36 | 251,595,886.76 | 1,809,595,623.03 |
| 投资活动现金流出小计 | 1,696,521,987.91 | 907,428,678.67 | 451,959,010.27 | 2,456,742,565.83 |
| 投资活动产生的现金流量净额 | -246,646,333.28 | -62,871,984.31 | -200,363,123.51 | -647,146,942.8 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 853,922,308.26 | 463,055,847.31 | 63,083,621.06 | 734,601,065 |
| 筹资活动现金流出小计 | 1,214,020,346.01 | 773,032,527.09 | 215,781,703.52 | 979,119,948.28 |
| 筹资活动产生的现金流量净额 | -360,098,037.75 | -309,976,679.78 | -152,698,082.46 | -244,518,883.28 |
| 汇率变动对现金及现金等价物的影响 | -393,519.86 | -294,450.8 | -140,740.23 | -133,423.32 |
| 现金及现金等价物净增加额 | 34,544,518.31 | 36,499,501.28 | -48,653,826.7 | -54,618,080.91 |
| 期末现金及现金等价物余额 | 302,806,500.07 | 304,761,483.04 | 219,608,155.06 | 268,261,981.76 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 36,499,501.28 | - | -54,618,080.91 |